Track market-moving stories before they get noisy

© Quality Stock Arts / Shutterstock.com

Three stocks, one question: can any of them triple by 2027? NVIDIA (NASDAQ:NVDA | NVDA Price Prediction), Advanced Micro Devices (NASDAQ:AMD), and Broadcom (NASDAQ:AVGO) are the three horses in the AI silicon race, and each is priced very differently.

NVIDIA CEO Jensen Huang calls the AI factory buildout “the largest infrastructure expansion in human history.” Broadcom’s Hock Tan says “the momentum continues” with Q3 AI semi revenue set to grow over 200% year-over-year to $16 billion. I want to know which one has a realistic shot at 3x by 2027.

Why a 3x in 18 Months Is a Stretch for All Three None of these are cheap. AMD trades at a trailing P/E of 185, Broadcom at 67, NVIDIA at 32. AMD is already up 160.5% YTD and 286.99% over one year. Broadcom is up 46.3% in a year. NVIDIA has lagged its peers with a 13.25% YTD gain, weighed down by China H20 revenue uncertainty.

High betas (2.211 for NVDA, 2.469 for AMD, 1.462 for AVGO) mean each can move sharply, but tripling still requires either monster EPS beats or extreme multiple expansion.

NVIDIA: The Cleanest Setup, Still a Long Shot NVIDIA’s Q1 FY27 revenue hit $81.61B, up 85.2% YoY, with Data Center at $75.25B (+92%). Analyst consensus target is $301.62 and our base case sits at $260.92, bull case $302.07. From $210.96, a 3x target of $633 requires a gain of 200%.

With forward EPS of $8, that implies a forward P/E of 79x, versus a current forward P/E of 26x. Doable only if FY28 EPS blows past $12 and the multiple stays north of 50x. Possible in a runaway AI capex year. Not our base case.

AMD: The Momentum Trade, But the Math Is Punishing AMD Q1 FY26 revenue was $10.25B (+37.9%) with Data Center at $5.78B (+57%). CEO Lisa Su flagged that “customer engagement around MI450 Series and Helios is strengthening, with leading customer forecasts exceeding our initial expectations.”

Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.

The Meta deal covers up to 6 GW of AMD Instinct GPUs. Our base case is $608.05, bull case $637. From $557.89, a 3x of $1,700 requires a gain of 200%. Against forward EPS of $6.87, that implies a forward P/E of 247x. AMD is already priced for perfection at 81x forward. This one is off the table by 2027.

Broadcom: The Dark Horse With a $100B Goal Broadcom guided Q3 revenue to $29.4B (+84% YoY), and management’s stated goal is to exceed $100B in AI sales by 2027. AI semi revenue grew 143% YoY to $10.8B last quarter. Analyst consensus is $523.73 with 92% bullish sentiment.

Our base case is only $417.83, bull $533.12. From $399.97, a 3x target of $1,200 requires a gain of 200%. On forward EPS of $12, that is a forward P/E of 100x. Current forward P/E is 33x. Aggressive, but at least directionally rational if custom silicon inflects.

The Bottom Line: Who Wins by 2027? Verdict: none of the three triples by July 2027 in my base case. The exact required gain is 200% for each. NVIDIA has the cleanest path because its forward P/E of 24 gives it the most room to re-rate on earnings.

AMD needs a miracle at 81x forward already. Broadcom sits in the middle with the strongest AI revenue trajectory but a heavy multiple. What derails all three? A hyperscaler capex pause. Returns at this level shouldn’t be expected every year, but we’ve outlined the blueprint for how NVIDIA could reach $633 in 2027.

Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.

Contact [email protected] for any questions or corrections.

Fastenal (FAST - Free Report) came out with quarterly earnings of $0.33 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.29 per share a year ago. These figures are adjusted for non-recurring items.

A quarter ago, it was expected that this maker of industrial and construction fasteners would post earnings of $0.3 per share when it actually produced earnings of $0.3, delivering no surprise.

Over the last four quarters, the company has not been able to surpass consensus EPS estimates.

Fastenal, which belongs to the Zacks Industrial Services industry, posted revenues of $2.39 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.87%. This compares to year-ago revenues of $2.08 billion. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Fastenal shares have added about 17.2% since the beginning of the year versus the S&P 500's gain of 9.8%.

What's Next for Fastenal?While Fastenal has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Fastenal was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.33 on $2.37 billion in revenues for the coming quarter and $1.24 on $9.11 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Industrial Services is currently in the bottom 24% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Distribution Solutions Group (DSGR - Free Report) , has yet to report results for the quarter ended June 2026.

This industrial products and tools maker is expected to post quarterly earnings of $0.38 per share in its upcoming report, which represents a year-over-year change of +8.6%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Distribution Solutions Group's revenues are expected to be $521.5 million, up 3.8% from the year-ago quarter.

New data shows restaurants are influencing where travelers go, where they stay and how they plan, with 61% of Americans having chosen a destination because of its food or restaurant scene

, /PRNewswire/ -- OpenTable today revealed its 2026 Top 100 Hotel Restaurants in America, as new consumer research and dining data show that hotel restaurants are playing a bigger role in how Americans plan their travel, where to stay, and where to eat. Timed to the launch of its latest top dining list, OpenTable is also unveiling an evolution to Concierge, its AI-powered dining assistant, now available directly on the OpenTable homepage to power restaurant discovery and booking.

OpenTable's latest dining insights show that hotel restaurants are playing a bigger role in how people plan where to go, where to stay and what to book before they arrive. 61% of Americans have chosen a destination because of its food or restaurant scene, and among respondents planning to travel this summer, 60% have booked a hotel specifically because of its restaurant.1

That momentum is showing up in reservations. OpenTable data shows hotel restaurant dining by travelers this year is up 13% year-over-year and up 7% across all diners.2 To help diners decide where to book next, OpenTable revealed the 2026 Top 100 Hotel Restaurants in America, a guide to the hotel dining rooms worth planning around.3

"Restaurants aren't just an itinerary line item anymore, they're the anchor. Our research backs this up, as half of Americans have booked a hotel specifically because of its restaurant,"1 said Matt Davis, Head of North America Hotels at OpenTable. "This year's Top 100 list spotlights the hotel hotspots worth traveling for, and with our AI Concierge helping diners get instant answers to their culinary questions, OpenTable is making it even easier to turn inspiration into a seat at the table."

OpenTable's 2026 Travel and Dining Trends:

No Room Key Required: Hotel restaurants are no longer just for overnight guests. 92% of respondents have dined at a hotel restaurant when they were not staying at the hotel, showing how these dining rooms are becoming destinations for travelers and locals alike.1 Reservations Are Driving the Itinerary: Younger travelers are planning where to eat before they arrive. 88% of Gen Z plan restaurant reservations ahead of time, with 46% thinking about reservations at the same time as booking their hotel.1 Table for One, Away from Home: Solo dining is finding a natural home in hotel restaurants and bars. OpenTable data shows parties of one by travelers are up 30% year-over-year to date2, while 71% of respondents would consider dining solo at a hotel restaurant or bar in the future.1 The Dining Concierge Goes Digital: Travelers want easier and convenient ways to find the right restaurant for every trip. 51% of respondents say they plan to use AI tools to help discover and book restaurant reservations while traveling this year, rising to 65% among Gen Z and 60% among Millennials.1 Digital Inspiration, Real-World Connection: Social media may help shape the dining experience, but travelers still want to be present once they arrive. While 58% of respondents say social media enhances dining, nearly three-quarters (71%) make a point to reduce their screen time while traveling to focus on in-person connection.1 "A great hotel restaurant immerses guests in the local culture, telling the story of a destination through its seasons, local ingredients and customs. Guests want to truly experience a city or a place through their stay. At SingleThread, we embrace the philosophy of Ichigo ichie - 'one chance and one encounter' - ensuring that no matter how many times a guest returns, they always experience a unique moment in time," said Kyle Connaughton, Chef-Owner of SingleThread Farm | Restaurant | Inn. "Guests are also embracing being present in the moment; more than ever, we notice that guests deeply value the opportunity to step away from screens and the busy, modern world to connect with both the land and each other."

OpenTable Launches Update to AI-Powered Dining Assistant

Nearly half of Americans (48%) say they spend more time researching where to eat and drink than any other part of a trip.1 Against that backdrop, OpenTable's updated Concierge tool can now help diners compare options and move from inspiration to booking more quickly.

Diners can describe exactly what they are looking for using natural language, from a spot locals love to the perfect date night nearby, and Concierge will surface options across OpenTable's global network of more than 65,000 restaurants, powered by verified reviews, menus and real-time availability.

The 2026 Top 100 Hotel Restaurants in America

For travelers looking to make dining part of the destination, the 2026 Top 100 Hotel Restaurants in America3 offers a guide to the restaurants worth adding to the itinerary - whether they are booking a summer getaway, planning a staycation or looking for a hotel dining room locals love.

To explore the full list, city-specific guides and understand flight and hotel pricing with the help of KAYAK, visit OpenTable's top hotel restaurant hub at: opentable.com/c/top-restaurants/top-100-hotel/.

The 2026 Top 100 Hotel Restaurants in America:

Arizona

Different Pointe of View (Pointe Hilton Tapatio Cliffs Resort) - Phoenix, AZ Le Âme Parisian Steakhouse at The Global Ambassador (The Global Ambassador) - Phoenix, AZ théa Mediterranean Rooftop at The Global Ambassador (The Global Ambassador) - Phoenix, AZ California

Gemma at Waldorf Astoria Beverly Hills (Waldorf Astoria Beverly Hills) - Los Angeles, CA SingleThread Restaurant & Inn (SingleThread Inn) - Healdsburg, CA Sky Room (Fairmont Breakers Long Beach) - Long Beach, CA Splashes at Surf & Sand Resort (Surf & Sand Resort) - Laguna Beach, CA The girl & the fig (Sonoma Hotel) - Sonoma, CA The Pony Room (Rancho Valencia Resort) - Rancho Santa Fe, CA Colorado

Alteno (Clayton Hotel & Members Club) - Denver, CO Quality Italian (HALCYON, a hotel in Cherry Creek) - Denver, CO The Grand Atrium at the Brown Palace (Brown Palace Hotel) - Denver, CO Wildflower (Gravity Haus Denver) - Denver, CO Slope Room (Gravity Haus Vail) - Vail, CO Swiss Chalet (Sonnenalp Hotel Vail) - Vail, CO Connecticut

Michael Jordan's Steak House (Mohegan Sun) - Uncasville, CT Florida

Akira Back (The Ray Hotel Delray Beach, Curio by Hilton) - Delray Beach, FL Bull & Bear Steakhouse (Waldorf Astoria Orlando) - Orlando, FL Capa (Four Seasons Resort Orlando at Walt Disney World® Resort) - Lake Buena Vista, FL Ceiba (Evermore Orlando Resort) - Orlando, FL Elliott Aster (The Vinoy Resort & Golf Club, Autograph Collection) - St. Petersburg, FL Evelyn's (Four Seasons Hotel and Residences Fort Lauderdale) - Fort Lauderdale, FL Gianni's at the Former Versace Mansion (The Villa Casa Casuarina) - Miami Beach, FL Knife & Spoon (The Ritz-Carlton Orlando, Grande Lakes) - Orlando, FL Lilac (The Tampa EDITION) - Tampa, FL Nami (Lake Nona Wave Hotel) - Orlando, FL Ocean Prime (Inn on Fifth) - Naples, FL Old Hickory Steakhouse (Gaylord Palms Resort) - Kissimmee, FL Ravello (Four Seasons Resort Orlando at Walt Disney World® Resort) - Lake Buena Vista, FL Salt (The Ritz-Carlton, Amelia Island) - Amelia Island, FL Sear + Sea (JW Marriott Orlando Bonnet Creek) - Orlando, FL Sushi by Bou (PGA National Resort) - Palm Beach Gardens, FL Takato (Conrad Fort Lauderdale Beach) - Fort Lauderdale, FL The London Club (Bellasera Hotel) - Naples, FL Hawaii

Alan Wong's (Kahari Resort) - Honolulu, HI Arancino at The Kahala (The Kahala Resort) - Honolulu, HI CanoeHouse (Mauna Lani Resort) - Kamuela, HI Ferraro's Restaurant & Bar (Four Seasons Resort Maui at Wailea) - Wailea, HI Michel's at the Colony Surf (Colony Surf) - Honolulu, HI Mina's Fish House (Four Seasons Resort O'ahu at Ko Olina) - Kapolei, HI Nobu Grand Wailea Maui (Grand Wailea Resort - Maui) - Wailea, HI NOE Italian (Four Seasons Resort O'ahu at Ko Olina) - Kapolei, HI The Signature Prime Steak & Seafood (Ala Moana Honolulu by Mantra) - Honolulu, HI Tidepools (Grand Hyatt Kauai) - Poipu, HI Ulu (Four Seasons Resort Hualalai) - Kailua-Kona, HI Wolfgang Puck's Spago (Four Seasons Resort Maui at Wailea) - Wailea, HI Idaho

Chandlers Steakhouse (Hotel 43) - Boise, ID Illinois

Cabra (The Hoxton Chicago) - Chicago, IL Cindy's Rooftop (Chicago Athletic Association) - Chicago, IL Gibsons Bar & Steakhouse (DoubleTree by Hilton Hotel Chicago O'Hare Airport - Rosemont) - Rosemont, IL Shanghai Terrace (The Peninsula Chicago) - Chicago, IL Kentucky

Repeal Oak Fired Steakhouse (Hotel Distil, Autograph Collection) - Louisville, KY Louisiana

Compère Lapin (Old No. 77 Hotel & Chandlery) - New Orleans, LA Jack Rose (Pontchartrain Hotel) - New Orleans, LA Massachusetts

Contessa (The Newbury, Boston) - Boston, MA Mooo Beacon Hill (XV Beacon) - Boston, MA Maryland

Ammoora (Ritz-Carlton Residences, Baltimore) - Baltimore, MD Bygone (Four Seasons Hotel Baltimore) - Baltimore, MD Maine

Earth at Hidden Pond (Hidden Pond) - Kennebunkport, ME White Barn Inn (White Barn Inn) - Kennebunk, ME North Carolina

Blue Ridge (Omni Grove Park Inn) - Asheville, NC Herons (The Umstead Hotel and Spa) - Cary, NC Luminosa (The Flat Iron Hotel) - Asheville, NC The Dining Room at Biltmore Estate (The Inn on Biltmore Estate) - Asheville, NC The Restaurant at Gideon Ridge (The Inn At Gideon Ridge) - Blowing Rock, NC New Jersey

Il Mulino New York (Hard Rock Hotel & Casino) - Atlantic City, NJ Nevada

Anthony's Prime Steak & Seafood (M Resort Spa Casino) - Henderson, NV Beauty & Essex (The Cosmopolitan of Las Vegas Autograph Collection) - Las Vegas, NV CATCH - ARIA (ARIA Resort & Casino) - Las Vegas, NV Cheri Rooftop (Paris Las Vegas) - Las Vegas, NV Eiffel Tower Restaurant (Paris Las Vegas) - Las Vegas, NV Gallagher's Steakhouse (New York Hotel & Casino) - Las Vegas, NV Hank's Fine Steaks & Martinis at Green Valley Ranch Resort Spa & Casino (Green Valley Ranch Resort Spa & Casino) - Henderson, NV Javier's Restaurant (ARIA Resort & Casino) - Las Vegas, NV Lago at Bellagio (Bellagio Hotel & Casino) - Las Vegas, NV Oscar's Steakhouse at the Plaza Hotel & Casino (Plaza Hotel & Casino) - Las Vegas, NV Wolf by Vanderpump at Caesars Republic Lake Tahoe (Caesars Republic Lake Tahoe) - Stateline, NV Zuma Las Vegas (The Cosmopolitan of Las Vegas Autograph Collection) - Las Vegas, NV New York

Cecconi's Dumbo (Soho House) - Brooklyn, NY Majorelle at The Lowell (The Lowell Hotel) - New York, NY Nubeluz (Ritz-Carlton New York, NoMad) - New York, NY TAO Downtown (The Maritime Hotel) - New York, NY The Palm Court at The Plaza Hotel (The Plaza Hotel) - New York, NY Zou Zou's (Pendry Manhattan West) - New York, NY Pennsylvania

Jean-Georges Philadelphia (Four Seasons Hotel Philadelphia) - Philadelphia, PA SkyHigh (Four Seasons Hotel Philadelphia) - Philadelphia, PA Vernick Fish (Four Seasons Hotel Philadelphia) - Philadelphia, PA Puerto Rico

Levant by Chef Michael White (La Concha Resort) - San Juan, PR South Carolina

Post House (Post House Inn) - Mount Pleasant, SC River House at Montage Palmetto Bluff (Montage Palmetto Bluff) - Bluffton, SC Texas

97 West Kitchen & Bar at Hotel Drover (Hotel Drover, Autograph Collection) - Fort Worth, TX Dean's Italian Steakhouse (JW Marriott Austin) - Austin, TX Kappo Kappo (Austin Proper Hotel) - Austin, TX Lutie's (Commodore Perry Estate, Auberge Resorts Collection) - Austin, TX Mastro's Steakhouse (The Post Oak Hotel) - Houston, TX Signature (Signia by Hilton La Cantera Resort & Spa) - San Antonio, TX Sister (Casa Duro) - Dallas, TX Stillwell's (Hôtel Swexan) - Dallas, TX Trick Rider (Omni PGA Frisco Resort) - Frisco, TX Washington, D.C.

Bourbon Steak (Four Seasons Hotel Washington, D.C.) - Washington D.C. 1 Consumer Research Methodology: An online survey was conducted by Ripple Research among 1500 US residents who have dined in a restaurant located in a hotel within the last 5 years or less, and major cities weighted at 200. Fieldwork was carried out between May 28th, 2026 and June 2nd, 2026. All data was collected in accordance with MRS (Market Research Society) and ESOMAR guidelines, ensuring ethical standards and robust data quality.
2 OpenTable Dining Data: OpenTable looked at seated diners from online reservations for all active hotel restaurants on the OpenTable platform in the US from January 1, 2026 - April 19, 2026, and compared it to the same time period the year prior. 
3 The Top 100 Hotel Restaurants in America: The Top 100 Hotel Restaurants in America for 2026 list is generated from over 10,000,000 reviews from verified OpenTable diners and dining metrics from May 1, 2025 - April 30, 2026. Restaurants with a minimum threshold of diner reviews were considered and evaluated by a compilation of unique data points, including diner ratings and the percentage of five star reviews. Metrics were weighted to comprise an overall score. The resulting list appears A-Z, not in ranked order.

About OpenTable
OpenTable, a global leader in restaurant tech and part of Booking Holdings, Inc. (NASDAQ: BKNG), helps more than 65,000 restaurants worldwide fill 1.9 billion seats a year. OpenTable's world-class technology empowers restaurants to focus on what matters most - their team, their guests, and their bottom line - while enabling diners to discover and book the perfect restaurant for every occasion.

SOURCE OpenTable, Inc.

Global financial technology leader [url="]FIS[/url]Â (NYSE: FIS) has received two major industry awards recognizing innovation in risk technology. FIS was nam

HomeStock IdeasLong IdeasFinancials 

SummaryFidelity National Information Services is rated a 'BUY' with a $90/share price target, reflecting a 15% annualized upside at 15x P/E.Despite slow revenue growth and Worldpay divestiture, FIS demonstrates resilient fundamentals, 10% AEPS growth in 2025, and a 4.2% well-covered dividend yield.FIS trades at less than 7x P/E, a deep discount to historical multiples, with market pessimism disconnected from its robust earnings and sticky, mission-critical client base.I plan to average down and build a full position, as restructuring costs fade and client budgets stabilize, expecting significant re-rating potential.Looking for more investing ideas like this one? Get them exclusively at Wolf of Value. Learn More » Morsa Images/DigitalVision via Getty Images

In this article, I'll be reviewing Fidelity National Information Services (FIS).It's been about 2 years since I last covered this business, and the business has not done well for itself in terms

35.31K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of FIS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give financial advice. It may be structured as such, but it is not financial advice. Investors are required and expected to do their own due diligence and research prior to any investment. Short-term trading, options trading/investment and futures trading are potentially extremely risky investment styles. They generally are not appropriate for someone with limited capital, limited investment experience, or a lack of understanding for the necessary risk tolerance involved. I own the European/Scandinavian tickers (not the ADRs) of all European/Scandinavian companies listed in my articles. I own the Canadian tickers of all Canadian stocks I write about. Please note that investing in European/Non-US stocks comes with withholding tax risks specific to the company's domicile as well as your personal situation. Investors should always consult a tax professional as to the overall impact of dividend withholding taxes and ways to mitigate these.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

, /PRNewswire/ -- For the four weeks ending June 27, 2026, U.S. private employers added an average of 19,750 jobs per week, according to the NER Pulse, a weekly update of the monthly ADP National Employment Report (NER). 

Hiring slowed for the third straight week. These numbers are preliminary and could change as new data is added.

ADP Research Week ending

Change

(Four-week moving
average, seasonally
adjusted)

6/27/2026

19,750

6/20/2026

21,000

6/13/2026

24,250

6/6/2026

30,750

5/30/2026

26,500

5/23/2026

29,000

5/16/2026

30,500

5/9/2026

35,750

5/2/2026

40,750

4/25/2026

33,000

4/18/2026

30,250

4/11/2026

39,250

The NER Pulse is an estimate of the week-over-week change in employment based on a four-week moving average. These estimates are based on ADP's finely tuned, high-frequency data. The data is seasonally adjusted and have a two-week lag to allow for more complete and accurate estimates of real-time employment trends.

The NER Pulse, including 12 weeks of historical data, publishes every Tuesday at 8:15 a.m. ET, except weeks when ADP Research publishes the monthly National Employment Report which is built on a reference week that includes the 12th day of the month. The press release is available Tuesdays at 8:15 a.m. ET in the ADP Media Center. The NER Pulse is also available shortly after 8:15 a.m. ET on release days at ADP Research and in Main Street Macro.

The next NER Pulse will be released July 21, 2026. For upcoming release dates please refer to the calendar on the NER website.

The ADP National Employment Report and the NER Pulse are produced by ADP Research in collaboration with the Stanford Digital Economy Lab.

About ADP Research 
The mission of ADP Research is to make the future of work more productive through data-driven discovery. Companies, workers, and policy makers rely on our finely tuned data and unique perspective to make informed decisions that impact workplaces around the world.

To subscribe to monthly email alerts or obtain additional information about ADP Research, including employment and pay data, methodology, and a calendar of release dates, please visit https://www.adpresearch.com.

About ADP (NASDAQ: ADP)
ADP has been shaping the world of work with innovation and expertise for more than 75 years. As a global leader in HR and payroll solutions, ADP continuously works to solve business challenges for our clients and their workers, from simple, easy-to-use tools for small businesses to fully integrated platforms for global enterprises – and everything in between. Always Designing for People means we're focused on just that – people. We use our unmatched AI-driven insights and proven expertise to design innovative solutions that help people achieve greater success at work. More than 1.1 million clients across 140+ countries rely on ADP's exceptional service to support their people and drive their business forward. HR, Talent, Time Management, Benefits, Compliance, and Payroll. Learn more at ADP.com.

ADP, the ADP logo, and Always Designing for People, ADP National Employment Report, and ADP Research are registered trademarks of ADP, Inc. All other marks are the property of their respective owners.

Copyright © 2026 ADP, Inc. All rights reserved.

SOURCE ADP, Inc.

July 14, 2026 08:01 ET  | Source: Sysco Corporation

HOUSTON, July 14, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) will host a conference call and webcast to discuss its fourth quarter and fiscal year 2026 financial results at 10 a.m. ET on Tuesday, August 4, 2026.

All interested parties are invited to listen online at investors.sysco.com. Prior to the conference call and webcast, the company will also issue a news release and post a slide presentation in the investor relations section of its website. A replay of the webcast will be available online shortly after the live webcast is completed.

For purposes of public disclosure, including this and future similar events, Sysco uses the investor relations section of its website, found at investors.sysco.com, as the primary channel for publishing key information to its investors, some of which may contain material and previously non-public information.

About Sysco

Sysco is the global leader in selling, marketing and distributing food and related products to customers who prepare meals away from home. This includes restaurants, healthcare and educational facilities, lodging establishments, entertainment venues, and more. Sysco operates 337 distribution centers, in 10 countries, with 75,000 colleagues serving approximately 730,000 customer locations. The company generated sales of more than $81 billion in fiscal year 2025 that ended June 28, 2025.

As the world’s largest food-away-from-home distributor, Sysco offers customized supply chain solutions, bespoke specialty product offerings, and culinary support to drive customers to innovate and optimize their operations. We act as a trusted business partner to our customers, helping them grow through our industry-leading portfolio that includes fresh produce, premium proteins, specialty products, sustainably focused items, equipment and supplies, and innovative culinary solutions.

For more information, visit www.sysco.com. For important news and key information for Sysco investors, visit the Investor Relations section of the company’s website at investors.sysco.com.

For more information contact:  Kevin KimCassandra MauelInvestor ContactMedia [email protected]@sysco.comT 281-584-1219 T 281-584-1390   SYY-INVESTORS

New survey finds Americans spend more than six hours each week on meal planning, grocery shopping, cooking and cleanup.

, /PRNewswire/ -- Time is the new currency of wellness, and Americans are spending too much of it at the grocery store or in the kitchen. According to a new survey from Tempo, a ready-to-heat meal delivery service from the team at Home Chef, Americans spend more than six hours each week on meal planning, grocery shopping, cooking and cleanup combined, totaling more than 300 hours, or 13 full days, every year.

Cook Never Club_Tempo Meals

Tempo Infographic

Cook Never Club Merch The toll goes beyond the clock. 42% of Americans say they've cut short time spent relaxing because of cooking and meal prep, and nearly one in three have skipped a workout or wellness activity. Eating well, it turns out, is coming at the cost of living well.

Introducing the Cook Never Club

To help people reclaim their time this summer, Tempo is launching the Cook Never Club, a community built around a simple idea: opting out of cooking shouldn't mean opting out of eating well.

The only membership requirement is to opt-out of cooking and opt-in to more time well spent. No fees, no gatekeeping, just a shared mindset for anyone who wants to Eat Better, Cook Never. The Cook Never Club will come to life through exclusive merchandise giveaways, social content and in-person wellness events throughout the summer.

The Data Behind the Movement

Tempo's survey surfaces a growing tension at the center of American life, which is that people want to eat healthier, but the daily time and labor involved is standing in the way

83% of Americans say they'd like to improve the way they eat 50% say cooking is more frustrating than it's worth 38% have ordered takeout despite having groceries at home, simply because they didn't have the energy to cook 67% say getting back time lost to food-related tasks would be extremely or very valuable This isn't a motivation problem, it's a food friction problem.

What Tempo Offers

Tempo delivers fully prepared, single-serve meals ready to enjoy in just two minutes, with no meal planning, no prepping,no cleanup and especially, no cooking. Each meal is made with fresh ingredients on a menu approved by registered dietitians, so eating well doesn't come with compromise.

Customers choose from more than 20 rotating weekly meals, many featuring:

30+ grams of protein Fewer than 35 grams of carbohydrates 20%+ of the daily value of fiber GLP-1 Smart, wellness forward options for those managing metabolic wellness goals Gut-friendly ingredients Side Quests Welcome

Part of the Cook Never Club philosophy is that the hours saved in the kitchen and grocery store should go toward things that actually bring joy. Maybe that's a pottery class, bird watching, a sunrise run or finally learning to play mahjong. The Tempo team is taking on a side quest of their own and partnering with RISE Pilates Chicago for three free outdoor Pilates events this summer.

Tempo's Cook Never Club x RISE Pilates at Oak Street Beach

When: July 17, July 31 and August 7 at 6:00 a.m. CT Where: Oak Street Beach, Chicago, Illinois What: Free lakeside Pilates, Cook Never Club merchandise and a chance to win one month of free Tempo meals To learn more about Cook Never Club or enter to win exclusive merchandise, visit eat.tempomeals.com/cook-never-club or follow @TempoMeals on Instagram for event updates, giveaways and more opportunities to Eat Better, Cook Never.

About Tempo

Launched in 2023, Tempo is a ready-to-heat meal delivery service from the team at Home Chef that delivers delicious, single-serving meals right to your door. These balanced, registered dietitian-approved menus offer a simple solution to mindful meal prep and cook in just 2 minutes. Tempo and Home Chef are a part of The Kroger Co. (NYSE: KR) Family of Companies. Find out more at tempomeals.com.

The Cook Never Club survey was conducted by We Are Talker among 1,000 nationally representative U.S. adults ages 20-40 from June 2 - 5, 2026. Results were weighted to reflect the national population.

SOURCE Home Chef

Few cybersecurity companies have created as much value for investors as CrowdStrike.

Over the past decade, the company has evolved from an endpoint security provider into one of the world's leading cybersecurity platforms. Along the way, it became a trusted vendor for enterprises and a standout performer in the software sector.

That success naturally raises an important question for investors today: Could SentinelOne (S +3.80%) replicate CrowdStrike's strategy and deliver similarly impressive returns?

Image source: Getty Images.

CrowdStrike's success story is bigger than endpoint security Many investors still associate CrowdStrike with endpoint security, which protects laptops, servers, and other devices from cyberthreats. But endpoint security wasn't the company's ultimate destination. It was the starting point.

CrowdStrike used its endpoint security products to win customers, then expanded those relationships by offering additional products, including cloud security, identity protection, threat intelligence, security operations, and data analytics.

Over time, customers adopted more of CrowdStrike's products, spent more money on its platform, and became increasingly dependent on its ecosystem. That strategy turned CrowdStrike into much more than a cybersecurity vendor. It became a security platform. And platform companies often enjoy some of the most attractive economics in software. They generate recurring revenue, deepen customer relationships over time, and benefit from their opportunities to sell additional services to their established customers.

Interestingly, SentinelOne appears to be pursuing a remarkably similar strategy.

Today's Change

(

3.80

%) $

0.68

Current Price

$

18.56

SentinelOne is trying to build its own platform Like CrowdStrike, SentinelOne initially made its name in endpoint security. Today, however, management is building something much broader.

The company's Singularity platform now includes cloud security, identity protection, security analytics, data capabilities, and AI-powered security tools. Rather than focusing on solving a single cybersecurity problem, SentinelOne aims to provide a central platform to help organizations manage cybersecurity across their operations.

That distinction matters. A company that sells one product must constantly find new customers to grow. A platform company can grow both by attracting new customers and selling more services to existing ones.

AI could make this opportunity even bigger The timing may also work in SentinelOne's favor.

Artificial intelligence is creating one of the largest technological shifts in decades. Businesses are rapidly adopting AI tools, assistants, and autonomous agents to improve productivity and automate tasks.

But every AI deployment creates new security challenges. Companies must protect the sensitive data that flows through AI systems. They must secure AI-powered applications and monitor increasingly complex digital environments.

As AI adoption accelerates, cybersecurity becomes even more important. That's where SentinelOne's platform approach could prove particularly valuable.

The company isn't simply helping customers defend against new threats. It is also using AI to improve cybersecurity itself. Its Purple AI platform -- its agentic AI service -- helps security teams investigate threats, analyze data, and respond to incidents more efficiently.

In other words, AI is increasing the need for robust cybersecurity tools while also making SentinelOne's products more capable.

CrowdStrike still has a significant head start Of course, investors should not ignore the challenges ahead for SentinelOne.

CrowdStrike remains the larger company by a wide margin. It generates more revenue, serves more enterprise customers, and enjoys stronger brand recognition. For perspective, CrowdStrike generated $1.4 billion in revenue in its latest quarter -- about 5 times as much as SentinelOne's $277 million.

For many chief information security officers, CrowdStrike is already a trusted and familiar choice. That reputation matters. When organizations evaluate cybersecurity vendors, they often prefer proven platforms with established track records. CrowdStrike's scale, ecosystem, and customer relationships give it meaningful advantages.

SentinelOne still has some work to do in order to reach that level of trust.

What does it mean for investors? To be fair, investors don't need SentinelOne to become the next CrowdStrike for the stock to be a profitable holding. The more important question is whether SentinelOne can become one of the handful of cybersecurity platforms that enterprises trust with their most critical systems.

CrowdStrike has already shown how valuable its business model can be. SentinelOne is now attempting a similar transition from a cybersecurity product company to a cybersecurity platform company.

Whether it will ultimately succeed remains uncertain. But if the company continues expanding its platform, growing customer adoption, and capitalizing on the growing importance of AI-driven security, it could become a major cybersecurity platform.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

The consensus story on Nio (NYSE:NIO | NIO Price Prediction) has been predictable for years: a cash-burning Chinese electric vehicle startup that was one funding round away from trouble. That narrative was not wrong. Full-year 2025 still produced a net loss of RMB 14.9 billion, and going-concern language appeared in the filings. The market still sees that company, even though the financials describe a different one.

The Cost Base Has Been Re-Engineered The Q1 FY2026 report tells the story. Gross margin came in at 19.0%, up from 7.6% a year earlier. Vehicle margin hit 18.8%, improving quarter-over-quarter for the fourth consecutive quarter. R&D expenses fell 40.7% year over year, and SG&A dropped 20.5%. CEO William Li noted that the “productivity or yield of RMB 2.0 billion in R&D investment is equivalent to perhaps RMB 3.5 billion in past years.”

Nio printed a GAAP net profit of RMB 282.7 million in Q4 2025. It then slipped back to a net loss of RMB 48.1 million in Q1, while holding non-GAAP adjusted operating profit of  RMB 66.76 million. Li was direct: “For full-year 2026, our financial target is to achieve positive non-GAAP operating profit.” The trajectory points toward sustained profitability, though more remains to be proved.

Three Brands, Three Segments Q1 deliveries hit 83,465 units, up 98.3% year on year, split across the NIO brand (58,543), ONVO (13,339), and FIREFLY (11,583). The all-new ES8 reached its 100,000 delivery milestone in just 215 days, holding about 49.7% market share in its price segment. Q2 guidance calls for 110,000 to 115,000 vehicles. (For readers thinking about beaten-down growth names, our Winners You Already Missed report walks through the framework.)

Battery Swap: From Liability to Moat The 3,972 power swap stations and more than 29,200 chargers were long framed as capital expenditure sinkholes. Other-sales margin reached 20.6%, a four-year high. Li called services and community “at an inflection point and entering a new growth phase.” That is a recurring, higher-margin revenue engine and a switching cost.

The Risks Are Genuine Shares trade at $4.93, down 89.0% over five years. Reddit sentiment shows bearish scores of 22 to 23, anchored to a thread titled “Holding a 90%+ loser for 6 years.” Germany registrations collapsed 88% in H1 2026, ES8 unit costs rose roughly $2,950 on raw materials, and shareholders’ equity is a thin $626 million. Analyst sentiment is positive, and the $7.35 consensus target signals a 49% gain.

Real risks remain, but the market is still pricing a company that no longer matches its own income statement.

Want Up To $1,000? SoFi Is Giving New Active Invest Users Free StockLooking to grow your money but unsure where to begin? SoFi Active Invest is offering a limited-time promotion—open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts.

From $0 commission trading to fractional shares and automated investing, this app is designed to simplify investing for everyone, whether you’re just starting or already experienced. Its easy to sign up and secure your bonus. 

Contact [email protected] for any questions or corrections.

U.S. Government Moves $297M in Crypto to Coinbase: Sale or Custody?

Seized Bitcoin, Ethereum MovesIn a similar development, an address containing Bitcoin seized from the defunct cryptocurrency exchange BTC-e moved $57.27 million in BTC.

Another wallet linked to Brian Krewson, the Oracle employee convicted of laundering millions in cryptocurrency for convicted drug traffickers, directly moved 30,000 ETH, worth $53 million, to Coinbase Prime.

“Will they be selling it all?” Arkham sparked intrigue, though no conclusive evidence supported it at the time of writing.

Big Sell Pressure Incoming?Movements from wallets tied to the government are not unusual. In the past, the Federal government has sold or auctioned cryptocurrencies it acquired through law enforcement actions, criminal probes, and asset seizures.

A notable example is billionaire Tim Draper, who bought nearly 30,000 BTC seized from the Silk Road darknet market by the U.S. Marshals Service, a Department of Justice agency, in 2014.

The USMS didn’t immediately return Benzinga’s request for confirmation on the latest transfer.

US Government: A BTC HODLer?The U.S. government holds 324,552 BTC, worth approximately $20.27 billion, and 28,394 ETH valued at $50.51 million, according to Arkham data.

Last year, President Donald Trump’s executive order established a Strategic Bitcoin Reserve funded by forfeited assets, with a provision to develop budget-neutral strategies for acquiring additional BTC.

Treasury Secretary Scott Bessent said last year that the government would stop selling the confiscated Bitcoin.

Price Action: At the time of writing, BTC was exchanging hands at $62,486.46, down 0.54% in the last 24 hours, according to data from Benzinga Pro.

Photo courtesy: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Technical Outlook and Geopolitical Pressures The 50-day EMA is drifting lower, and if it were to break down below the 200-day EMA, which it sits just below it, that would kick off a technical death cross, which, longer-term traders will a lot of times read as a very negative sign.

The $57 level has recently offered a bit of support. Breaking down below there could open up a move to the downside, but recently, it looks like the market’s happy just churning in this general vicinity. We do have other headaches to worry about, not the least of which would be announcements and statements coming out of the Middle East, which, of course, have played havoc with the bond market. Silver continues to be very choppy.

Clinical outcomes: Diranersen demonstrated efficacy across all studied doses at 18 months, with consistent results across multiple prespecified clinical endpoints; the 60 mg dose showed the strongest response with slowing of clinical decline on the cognitive endpoints—42% on ADAS-Cog13 and 50% on MMSE—alongside a 26% slowing on CDR-SBBiomarker response: Diranersen is the first tau-directed therapy to demonstrate robust reductions in both CSF total tau, with mean reductions of 50–65%, and brain tau pathology, as measured by PET, across all studied doses in a Phase 2 studyDose response: CDR-SB results favored diranersen versus placebo across all studied doses; higher doses were not associated with greater slowing of declineMechanism of action: Distinct from other tau-lowering approaches, diranersen targets MAPT mRNA to reduce the production of all tau isoforms, lowering both intracellular and extracellular tau protein CAMBRIDGE, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced data from the Phase 2 CELIA study evaluating diranersen, an investigational antisense oligonucleotide (ASO) therapy targeting tau, in individuals with early Alzheimer’s disease. The data, presented at the Alzheimer’s Association International Conference (AAIC) 2026, expand upon previously reported topline results and demonstrate a combination of meaningful clinical efficacy and robust biomarker effects, providing Phase 2 proof of concept for diranersen’s tau-directed mechanism of action. Based on the growing and consistent body of evidence from the Phase 1b and Phase 2 studies, Biogen plans to advance diranersen into confirmatory Phase 3 development.1

“The CELIA data provide some of the clearest evidence that reducing tau pathology can translate into clinically meaningful benefit,” said Professor Cath Mummery, Professor of Clinical Neurology at the UCL Queen Square Institute of Neurology and Consultant Neurologist at University College London Hospitals NHS Foundation Trust. “The magnitude of tau reduction and cognitive benefit observed in CELIA is among the most compelling reported to date in Alzheimer’s disease drug development and supports advancing diranersen to Phase 3 development.”

“The CELIA clinical, biomarker, and safety data presented at AAIC provide proof of concept and important evidence of diranersen’s novel tau-reduction mechanism of action translating into clinical benefit. If confirmed in Phase 3, diranersen could represent an important new therapeutic approach targeting one of the core pathologies of Alzheimer's disease,” said Priya Singhal, M.D., M.P.H., Executive Vice President and Head of Development at Biogen. “Patients and families urgently need new approaches that address the complexity of Alzheimer’s disease. We look forward to working with health authorities and the broader Alzheimer’s community as diranersen advances to Phase 3.”

Diranersen demonstrated efficacy across all studied doses at 18 months, with consistent efficacy across multiple prespecified secondary endpoints, including the Clinical Dementia Rating Sum of Boxes (CDR-SB), a global measure of cognition and daily function; ADAS-Cog13 and MMSE, measures of cognition; modified iADRS and ADCOMS, composite measures of cognition, function, and disease progression; as well as the individual cognitive and functional domains of CDR-SB. Diranersen 60 mg administered intrathecally every six months (n=60) showed the strongest response at 18 months. Compared with placebo (n=115), diranersen 60 mg demonstrated slowing of clinical decline by 0.54 points (26%) on CDR-SB; 42% on ADAS-Cog13; 50% on MMSE; 30% on modified iADRS; and 23% on ADCOMS. The majority of these endpoint differences achieved nominal statistical significance compared with placebo.

Clinical effects were also observed in the other studied dose regimens. Compared with placebo, diranersen 115 mg administered intrathecally every six months (n=115) and diranersen 115 mg administered intrathecally every three months (n=116) demonstrated slowing of clinical decline by 0.28 and 0.18 points (14% and 9%) on CDR-SB; 32% and 29% on ADAS-Cog13; 34% and 38% on MMSE; 29% and 18% on modified iADRS; and 21% and 7% on ADCOMS, respectively. At 18 months, no separation from placebo was observed across dose groups on ADCS-ADL-MCI, a measure of daily functioning, and longer-term follow-up continues to assess whether a longer duration of diranersen therapy impacts this endpoint. Of note, while ADCS-ADL-MCI results were inconsistent across dose regimens, slowing of functional decline based on the functional domains of CDR-SB favored diranersen across all studied doses.  

CELIA was designed with a primary endpoint of dose response on CDR-SB at 18 months to investigate whether higher doses of diranersen could provide greater clinical benefit. As previously disclosed, this was not observed, and the study did not meet its primary endpoint.

Diranersen demonstrated target engagement and robust reductions in cerebrospinal fluid (CSF) total tau across all studied doses, with mean reductions of 50–65% from baseline. In the tau PET imaging substudy (n=131), decreases from baseline were seen across all evaluated brain regions for all diranersen doses. Diranersen is the first tau-directed therapy to demonstrate reductions in both CSF total tau and brain tau pathology, as measured by PET, across all studied doses in a Phase 2 study.

Diranersen was generally well tolerated. During the placebo-controlled period, most participants who experienced adverse events had events that were mild or moderate in severity, non-serious, and did not result in treatment discontinuation or study withdrawal. The most frequent adverse events were procedural pain, post-lumbar puncture syndrome, and confusional state. Most adverse events of confusional state occurred within a few days of dosing and resolved within a week. Among participants who completed the placebo-controlled period, more than 90% elected to continue into the extension study. Amyloid-related imaging abnormalities (ARIA) are not anticipated with diranersen based on its tau-targeting mechanism of action, and the results from CELIA are consistent with that expectation.

The study enrolled a population representative of early Alzheimer’s disease, with baseline characteristics generally balanced across treatment groups. Participants had a mean age of 68 years, 51% were female, and 60% were classified as having mild cognitive impairment, with 40% having mild Alzheimer’s disease dementia. ApoE4 carriers represented approximately 69% of participants, including 23% homozygotes.

Additional analyses and data from CELIA and the ongoing long-term extension study will be presented at future scientific conferences.

A Media Snippet accompanying this announcement is available by clicking on this link.

Educational Program on Tau in Alzheimer’s Disease
At AAIC, Biogen is hosting an interactive booth offering an immersive journey into the role of tau in Alzheimer’s disease, from pathology to clinical presentation. Biogen is also expanding its educational efforts with a new e-learning module on KnowTau.com, building on the resources already available.

For more information, please see the AAIC 2026 program and visit the Biogen AAIC booth.

About diranersen (BIIB080)
Diranersen (BIIB080) is an investigational antisense oligonucleotide (ASO) therapy designed to target microtubule-associated protein tau (MAPT) mRNA to reduce the production of tau protein. Unlike many investigational approaches that have focused on targeting extracellular tau, diranersen is designed to reduce both intracellular and extracellular tau.

Diranersen is being investigated as a potential treatment for early Alzheimer’s disease. In 2025, the U.S. Food and Drug Administration (FDA) granted Fast Track designation to diranersen for the treatment of Alzheimer’s disease.

In December 2019, Biogen exercised a license option with Ionis Pharmaceuticals and obtained a worldwide, exclusive, royalty-bearing license to develop and commercialize diranersen. Diranersen was discovered by Ionis.   

About the CELIA Study
CELIA is a global Phase 2 randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety, and tolerability of diranersen in individuals with early Alzheimer’s disease. The study enrolled 416 participants with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s disease dementia. All participants enrolled in CELIA had not previously received anti-amyloid therapy.

The study evaluated three doses of diranersen administered intrathecally over an 18-month placebo-controlled treatment period: 60 mg every six months, 115 mg every six months, and 115 mg every three months.

The primary endpoint of CELIA was assessment of dose response for change from baseline on the Clinical Dementia Rating–Sum of Boxes (CDR-SB) at Week 76. Secondary and exploratory endpoints included additional clinical, biomarker, and imaging measures, including cerebrospinal fluid tau biomarkers and tau positron emission tomography (PET). Additional information on the study design is available in the ClinicalTrials.gov listing for the CELIA study.

An ongoing long-term extension (LTE) study is continuing to evaluate the long-term safety, tolerability, and durability of diranersen’s clinical benefit in early Alzheimer’s disease.

About Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.

We routinely post information that may be important to investors on our website at www.biogen.com. Follow us on social media - Facebook, LinkedIn, X, YouTube.

Biogen Safe Harbor 
This news release contains forward-looking statements, including, among others, relating to: the potential benefits, efficacy and safety of diranersen; the potential that, if confirmed in Phase 3, diranersen could represent a new therapeutic approach targeting one of the core pathologies of Alzheimer's disease; potential regulatory discussions, submissions, decisions and approvals and the timing thereof; the anticipated benefits, risks and potential of our collaboration arrangements; the potential of our commercial business and pipeline programs, including diranersen; and risks and uncertainties associated with drug development and commercialization. These forward-looking statements may be accompanied by such words as “aim,” “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “hope,” “intend,” “may,” “objective,” “outlook,” “plan,” “possible,” “potential,” “predict,” “project,” “prospect,” “should,” “target,” “will,” “would” or the negative of these words or other words and terms of similar meaning. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early-stage clinical trials may not be indicative of full results or results from later stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements. Given their forward-looking nature, these statements involve substantial risks and uncertainties that may be based on inaccurate assumptions and could cause actual results to differ materially from those reflected in such statements.

These forward-looking statements are based on management’s current beliefs and assumptions and on information currently available to management. Given their nature, we cannot assure that any outcome expressed in these forward-looking statements will be realized in whole or in part. We caution that these statements are subject to risks and uncertainties, many of which are outside of our control and could cause future events or results to differ materially from those stated or implied in this document, including, among others, uncertainty of our long-term success in developing, licensing, or acquiring other product candidates or additional indications for existing products; expectations, plans, prospects and timing of actions relating to product approvals, approvals of additional indications for our existing products, sales, pricing, growth, reimbursement and launch of our marketed and pipeline products; the potential impact of increased product competition in the biopharmaceutical and healthcare industry, as well as any other markets in which we compete, including increased competition from new originator therapies, generics, prodrugs and biosimilars of existing products and products approved under abbreviated regulatory pathways; our ability to effectively implement our corporate strategy; difficulties in obtaining and maintaining adequate coverage, pricing, and reimbursement for our products; the drivers for growing our business, including our dependence on collaborators and other third parties for the development, regulatory approval, and commercialization of products and other aspects of our business, which are outside of our full control; risks related to commercialization of biosimilars, which is subject to such risks related to our reliance on third-parties, intellectual property, competitive and market challenges and regulatory compliance; the risk that positive results in a clinical trial may not be replicated in subsequent or confirmatory trials or success in early stage clinical trials may not be predictive of results in later stage or large scale clinical trials or trials in other potential indications; risks associated with clinical trials, including our ability to adequately manage clinical activities, unexpected concerns that may arise from additional data or analysis obtained during clinical trials, regulatory authorities may require additional information or further studies, or may fail to approve or may delay approval of our drug candidates; and the occurrence of adverse safety events, restrictions on use with our products, or product liability claims; and any other risks and uncertainties that are described in reports we have filed with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. 

These statements speak only as of the date of this press release and are based on information and estimates available to us at this time. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove inaccurate, actual results could vary materially from past results and those anticipated, estimated or projected. Investors are cautioned not to put undue reliance on forward-looking statements. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and in our subsequent reports on Form 10-Q. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements whether as a result of any new information, future events, changed circumstances or otherwise. 

Digital Media Disclosure 
From time to time we have used, or expect in the future to use, our investor relations website (investors.biogen.com), the Biogen LinkedIn account (linkedin.com/company/biogen-) and the Biogen X account (https://x.com/biogen) as a means of disclosing information to the public in a broad, non-exclusionary manner, including for purposes of the SEC’s Regulation Fair Disclosure (Reg FD). Accordingly, investors should monitor our investor relations website and this social media channel in addition to our press releases, SEC filings, public conference calls and webcasts, as the information posted on them could be material to investors. 

Reference:

Shulman M, Wu S, Ziogas N, et al. Exploratory analyses of clinical outcomes from the BIIB080 phase 1b study in mild Alzheimer’s disease. Nature Aging. 2026;6:445-453. https://doi.org/10.1038/s43587-025-01031-9. Accessed July 2026.

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that its partner, Biogen, shared data from the Phase 2 CELIA study evaluating diranersen, an investigational antisense oligonucleotide (ASO) therapy targeting tau, in individuals with early Alzheimer's disease. The data, presented at the Alzheimer's Association International Conference (AAIC) 2026, expand upon previously reported topline results and demonstrate a combination of meaningful clinical effi.

Over six years, Align has contributed more than $2M to Operation Smile's student programs to send the next generation of global health advocates to the world stage

, /PRNewswire/ -- Operation Smile, a global nonprofit deeply committed to closing the gap in surgical and health care access, today announced Align Technology, Inc. (Nasdaq: ALGN) as the title sponsor of its 2026 International Student Leadership Conference (ISLC), marking the sixth consecutive year of this sponsorship. Through nearly $3.8 million in total contributions benefiting Operation Smile's students and surgical programs, Align Technology is a key global partner, supporting youth leadership and access to surgical care, demonstrating an enduring commitment to health care and the development of tomorrow's global health leaders.

ISLC 2026, the conference's 34th year, will take place in Bangkok, Thailand from July 17 – 23, 2026, bringing together approximately 280 high school and university participants from 37 countries. Through Align Technology's continued support, financial barriers are being removed for students with cleft conditions from low- and middle-income countries, creating a more inclusive and impactful global youth health movement.

An Impactful Year for Global Youth Leadership

ISLC 2026 is a testament to the unstoppable momentum of youth-led global health advocacy. Among the highlights of this year's conference:

280 total participants from high schools and universities ~100 scholarship recipients from all participating regions 10 participants attending under the Cleft Connect group scholarships, bringing their lived experience to lead and shape conversations within the global health movement Largest university cohort since the program reopened to university-level participants, with 37 university students attending 37 countries represented – a powerful signal of the program's ever-expanding global reach More than 90 participants from Asia, including students from China, the Philippines, Vietnam, India, and Thailand, with students from Nepal and Palestine joining for the first time, reflecting the depth of Operation Smile's impact across the region First cohort of Align Scholar recipients from the United States and Canada  Bridging Barriers to Leadership
Through the Align Scholars program, approximately 100 students receive full scholarships covering travel and conference fees. Many of the Align Scholar program recipients were born with a cleft condition and the majority are from low- and middle-income countries.

"At Operation Smile, we believe the future of global health lies in the next generation," said Brigette Clifford, AVP Student Programs, Operation Smile. "Align Technology has been our most steadfast partner for six years. Their investments reflect their commitment to oral health and in young people's power to change the world. This year alone, approximately 100 students will attend ISLC knowing someone believed in them."

"Align Technology is proud to be a strong supporter of Operation Smile's life-changing work of to provide free surgeries and multi-modal care to people with cleft conditions," said Julie Paulsen, VP HR, Employee Programs, and Community Engagement, Align Technology. "The ISLC program, sponsored by Align, is a wonderful opportunity for students to develop leadership skills, positively impact their local communities, and raise awareness and advocacy of Operation Smile's remarkable programs around the world."

A 40+ Year Legacy, Accelerating Forward

Since its founding more than 40 years ago, Operation Smile has expanded access to life-changing surgical and health care across the globe, partnering with local medical leaders, health ministries, universities, and NGOs in more than 35 countries. The organization's bold commitment, Operation 100, is investing in local frontline health workers and strengthening district hospitals to bring essential surgical care closer to patients who need it most.

ISLC student leaders are an important part of that mission. They graduate with leadership skills, a global network of changemakers, and a deeper understanding of health equity. Many return home committed to strengthening their local health systems—some as medical volunteers, others as leaders within their communities—helping to expand access to care. Align Technology's philanthropic philosophy is to support organizations such as Operation Smile whose vision ties closely to Align's purpose of- transforming smiles and changing lives.

To learn more about Operation Smile's transformative partnership with Align Technology, click here: Align Technology.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for approximately 299.5 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 29 years, Align has helped doctors treat approximately 22.8 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, its integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.

About Operation Smile

Operation Smile is a leading global nonprofit bridging the gap in access to essential surgeries and health care, starting with cleft surgery and comprehensive care. We provide medical expertise, training, mentorship, research and care through our dedicated staff and volunteers around the world, working alongside local governments, nonprofits and health systems, and supported by our generous donors and corporate partners. Visit operationsmile.org for more information.

Contact:
Elizabeth McDermott
[email protected]

SOURCE Operation Smile

Key Takeaways Trade Desk sees CTV as a major long-term growth driver as advertisers shift from linear TV.TTD said Disney, NBCUniversal and Netflix are advancing CTV advertising through programmatic efforts.TTD said video, including CTV, made up a low-50% share of business in first-quarter 2026. The Trade Desk, Inc. (TTD - Free Report) is benefiting from the continued momentum in connected TV (CTV), which remains one of the company's key long-term growth drivers. On the last earnings call, management highlighted that the transition of linear television to CTV is still in its early stages, creating a significant opportunity as advertisers increasingly shift toward data-driven advertising.

The company noted that the total addressable market for advertising continues to expand, supported by trends such as retail media, AI-powered search and chatbots, while the migration from linear TV to CTV further strengthens its long-term outlook. Despite a more challenging macroeconomic environment marked by geopolitical tensions, tariffs and economic uncertainty, Trade Desk believes sophisticated advertisers are becoming more deliberate and data-driven, creating opportunities for its platform.

TTD highlighted that premium publishers are increasingly embracing programmatic advertising, better data and improved supply chains to enhance advertising effectiveness. Disney, one of the largest CTV advertising publishers, continues to benefit from biddable programmatic advertising, lower ad loads and a direct relationship with Trade Desk. NBCUniversal is also supporting initiatives that improve CTV price discovery and advertiser signals, while Netflix continues to expand its advertising capabilities through technological enhancements with Trade Desk. Management stated that these developments reinforce the value of premium inventory and support greater advertiser participation across CTV.

Trade Desk also emphasized that improvements in advertising measurement are expected to support broader adoption of premium channels, such as CTV and audio. The company believes traditional last-touch attribution methods have limited the effectiveness of branding campaigns and premium inventory. As advertisers adopt more advanced measurement approaches and AI-driven decision-making, management expects greater investment in CTV campaigns that focus on long-term brand building rather than simply optimizing for lower-funnel metrics.

The company's first-quarter 2026 performance also reflected the continued strength of CTV. Management stated that CTV growth remained strong, supported by the ongoing shift away from linear television and increasing decisioned inventory from major publishers. Video, including CTV, represented a low-50% share of the company's business during the quarter and continued to increase as a percentage of total channel mix. Going ahead, Trade Desk plans to continue investing in AI-driven decisioning, retail media, CTV and identity while strengthening its platform to support long-term growth and help advertisers achieve measurable outcomes.

Taking a Look at TTD’s CompetitorsPubMatic, Inc. (PUBM - Free Report) is gaining from accelerating AI adoption, expanding CTV and mobile app advertising, and a more diversified demand-side platform (DSP) base. Its AI-powered AgenticOS and Agentic advertising solutions are driving new revenue streams, improving campaign automation and increasing customer adoption. Growth in emerging revenues, CTV, mobile apps and Commerce Media, supported by partnerships with Amazon, Walmart Connect and PayPal, is strengthening the company's growth profile. PubMatic's owned infrastructure and AI-driven efficiencies are lowering costs and expanding margins, while its broader publisher network, global expansion and growing mid-market DSP relationships position the company for sustained double-digit revenue growth.

Amazon (AMZN - Free Report) is gaining from aggressive international expansion, a diversified business model and broad-based AI adoption across its operations. International growth is being supported by continued investments in logistics infrastructure across Asia, Europe and Latin America, driving higher sales and improving profitability. Amazon Web Services remains a key growth engine, benefiting from rising cloud and AI demand, while the advertising business continues expanding as brands increase spending on its platform. The company is also integrating AI across AWS, logistics and e-commerce operations, enhancing efficiency, strengthening customer experiences and supporting long-term revenue growth and margin expansion across its businesses.

TTD’s Price Performance, Valuation and EstimatesShares of TTD have plunged 75.3% in the past year against the Zacks Internet -Services industry’s rise of 83.9%.

Image Source: Zacks Investment Research

Valuation-wise, TTD seems attractive, as suggested by the Value Score of B. From a valuation standpoint, TTD trades at a forward price-to-sales of 2.78X, lower than the industry’s average of 7.63X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for TTD’s earnings has been revised upward over the past 30 days.

Image Source: Zacks Investment Research

TTD currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. 

SUNNYVALE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced new capabilities for its unified endpoint platform, FortiEndpoint, designed to help organizations securely adopt AI, protect sensitive data, and reduce risk. By bringing AI visibility and control, native data security, endpoint risk scoring, and FortiAI-assisted operations into FortiEndpoint, Fortinet enables security teams to better govern AI usage, reduce sensitive data exposure, enforce risk-aware access, and simplify security operations across distributed environments.

“Organizations need a simpler and more effective way to manage security as their environments become more complex and AI-enabled,” said Michael Xie, Founder, President, and CTO at Fortinet. “The Fortinet Security Fabric is designed to converge critical security and networking functions across the enterprise, helping customers reduce complexity, improve visibility, and strengthen protection. With FortiEndpoint, we are extending that strategy by consolidating security, secure access, data security, AI visibility, and assisted operations in a unified endpoint platform, delivered through one agent, one console, and one license.”

A Platform Approach to AI-Era Endpoint Security
As agents and AI-enabled applications become embedded in everyday work, organizations need better visibility, stronger governance, and integrated protection to securely enable AI while reducing endpoint risk and protecting sensitive data. These needs are even more urgent as threat actors move faster and use increasingly sophisticated techniques to exploit gaps across users, devices, applications, and data. The pressure security teams are facing is compounded by fragmented tools across protection, detection and response, secure access, and data security, which can slow security teams and limit visibility.

FortiEndpoint builds on the consolidation strategy previewed at Fortinet Accelerate 2026 by bringing AI visibility and governance, endpoint protection, detection and response, secure remote access, native data security, and FortiAI-assisted operations together through one agent, one console, and one license. Through integration with the Fortinet Security Fabric, endpoint telemetry and risk context can inform connected security controls, strengthening adaptive access, policy enforcement, and enterprise-wide visibility.

These capabilities help define Fortinet’s approach to endpoint security for the AI era, advanced through three key areas of innovation:

Securing AI Use at the Endpoint
FortiEndpoint provides centralized visibility and control over sanctioned and unsanctioned AI application and agent usage across endpoints, including installed AI apps, agents, and web-based tools. From a single view, organizations can identify agents and applications in use, monitor adoption, and understand user activity to help surface shadow AI, unmanaged applications, and unauthorized tool usage.

With granular guardrail policies, security teams can allow, restrict, monitor, or block applications based on corporate security, compliance, and data security requirements. This supports responsible AI adoption while reducing the risk of unsanctioned tools, sensitive data exposure, and policy violations.

Reducing AI-Driven Data Exposure and Insider Risk
FortiEndpoint now natively supports DLP to help secure AI interactions and reduce insider risk by automatically inspecting sensitive data exchanged with AI applications, agents, and web services. Built-in user coaching provides real-time policy guidance to help users understand acceptable AI usage and reduce risky behaviors without impacting productivity.

This helps prevent the leakage of sensitive data such as personally identifiable information, intellectual property, and financial information directly at the endpoint. By integrating DLP into FortiEndpoint, organizations can safely adopt AI while maintaining stronger data security and compliance controls without adding another point product or management layer.

Unifying Endpoint Security, Access, Data Security and AI-Assisted Operations
FortiAI-Assist is built into FortiEndpoint to simplify administration and accelerate day-to-day operations. Security teams can use natural language to investigate events, visualize findings, generate investigation summaries, identify high-risk devices, and troubleshoot issues. It also provides contextual insights, policy recommendations, and risk guidance to help analysts strengthen governance, prioritize threats, scale threat hunting, and improve efficiency through a unified management experience.

These assisted workflows are complemented by adaptive zero-trust capabilities with dynamic risk and compliance scoring. By continuously assessing endpoint health, compliance status, and risk posture, FortiEndpoint helps organizations make access decisions based on real-time context, so access to AI applications and protected resources can be adjusted as risk changes. This helps organizations reduce exposure, enforce more consistent policy, and safely support AI-enabled work.

Industry analysts are also recognizing the importance of this integrated approach as organizations look for practical ways to govern AI use without adding more tools and complexity.

“Fortinet is addressing what many CISOs need now: visibility into AI usage, control over sanctioned and unsanctioned tools, protection against sensitive data leakage, and real-time coaching to help employees use AI responsibly,” said Chris DePuy, Technology Analyst at 650 Group. “Delivering these capabilities through FortiEndpoint gives customers a practical way to manage AI risk with the same agent and license they already rely on for endpoint security.”

Read the blog and listen to the webinar for more detail on how FortiEndpoint helps organizations securely adopt AI, protect sensitive data, reduce risk, and simplify security operations. 

Availability
The new FortiEndpoint enhancements are expected to be available in Q3 2026. For more information, visit here.

Additional Resources

Read more about FortiEndpoint.Read more about the Fortinet Security Fabric.Learn about the Fortinet Open Ecosystem.Visit fortinet.com/trust to learn about Fortinet innovation, collaboration partners, product security processes, and enterprise-grade products.Read about how Fortinet customers are securing their organizations.Learn about Fortinet’s commitment to product security and integrity, including its responsible product development and vulnerability disclosure approach and policies.Follow Fortinet on X, LinkedIn, Facebook, and Instagram. Subscribe to Fortinet on our blog or YouTube. About Fortinet 

Fortinet (NASDAQ: FTNT) is a driving force in the evolution of cybersecurity and the convergence of networking and security. Our mission is to secure people, devices, and data everywhere, and today we deliver cybersecurity everywhere our customers need it with the largest integrated portfolio of over 50 enterprise-grade products. Well over half a million customers trust Fortinet's solutions, which are among the most deployed, most patented, and most validated in the industry. The Fortinet Training Institute, one of the largest and broadest training programs in the industry, is dedicated to making cybersecurity training and new career opportunities available to everyone. Collaboration with esteemed organizations from both the public and private sectors, including Computer Emergency Response Teams (“CERTS”), government entities, and academia, is a fundamental aspect of Fortinet’s commitment to enhance cyber resilience globally. FortiGuard Labs, Fortinet’s elite threat intelligence and research organization, develops and utilizes leading-edge machine learning and AI technologies to provide customers with timely and consistently top-rated protection and actionable threat intelligence. Learn more at https://www.fortinet.com, the Fortinet Blog, and FortiGuard Labs.

Copyright © 2026 Fortinet, Inc. All rights reserved. The symbols ® and ™ denote respectively federally registered trademarks and common law trademarks of Fortinet, Inc., its subsidiaries and affiliates. Fortinet’s trademarks include, but are not limited to, the following: Fortinet, the Fortinet logo, FortiGate, FortiOS, FortiGuard, FortiCare, FortiAnalyzer, FortiManager, FortiASIC, FortiClient, FortiCloud, FortiCore, FortiMail, FortiSandbox, FortiADC, FortiAgent, FortiAI, FortiAIOps, FortiAntenna, FortiAP, FortiAPCam, FortiAppSec, FortiAuthenticator, FortiBranchSASE, FortiCall, FortiCam, FortiCamera, FortiCarrier, FortiCART, FortiCASB, FortiCentral, FortiConnect, FortiController, FortiConverter, FortiDAST, FortiDATA, FortiDB, FortiDevice, FortiDDoS, FortiDeceptor, FortiDeploy, FortiDevice, FortiDevSec, FortiDLP, FortiEdge, FortiEDR, FortiEndpoint, FortiExplorer, FortiExtender, FortiFirewall, FortiFlex, FortiFone, FortiGSLB, FortiGuest, FortiHSM, FortiHypervisor, FortiIdentity, FortiInsight, FortiIsolator, FortiLink, FortiMonitor, FortiNAC, FortiNDR, FortiPAM, FortiPhish, FortiPoint, FortiPoints, FortiPortal, FortiPresence, FortiProxy, FortiRecon, FortiRecorder, FortiSASE, FortiSAT, FortiSEC, FortiSIEM, FortiSMS, FortiSOAR, FortiSOC, FortiSRA, FortiSwitch, FortiTelemetry, FortiTester, FortiTIP, FortiToken, FortiTrust, FortiVoice, FortiWAN, FortiWeb, FortiWiFi, FortiWLC, FortiWLM, FortiXDR, Lacework FortiCNAPP, Linksys, Intelligent Mesh, Velop, Max-Stream, Performance Perfected and SECURITY FABRIC. 

Other trademarks belong to their respective owners. Fortinet has not independently verified statements or certifications herein attributed to third parties and Fortinet does not independently endorse such statements. Notwithstanding anything to the contrary herein, nothing herein constitutes a warranty, guarantee, contract, binding specification or other binding commitment by Fortinet or any indication of intent related to a binding commitment, and performance and other specification information herein may be unique to certain environments.

Global energy technology company SLB (NYSE: SLB) today announced an agreement with Liberty Energy Inc. (NYSE: LBRT) to form a strategic alliance that will deli

Key Takeaways DuPont analysis breaks ROE into margin, asset efficiency and leverage for deeper stock insights.MAMA, EXPD, GWW and ECG passed DuPont-based screens backed by Zacks Rank #2 (Buy) ratings.DuPont helps spot quality firms and avoid high-ROE stocks driven mainly by excessive debt. Return on equity (ROE) is one of the most favored metrics of investors. It is a profitability ratio that measures earnings generated by a company from its equity. Investors can follow the ROE trend in companies and compare this to historical or industry benchmarks to pick a winning stock.

However, stepping beyond the basic ROE and analyzing it at an advanced level could lead to even better returns. Here is where the DuPont analysis comes into play. It is an analytical method that examines three major elements – operating management, management of assets and the capital structure – related to the financial condition of a company. Below we show how DuPont breaks down ROE into its different components:

ROE = Net Income/Equity

Net Income / Equity = (Net Income / Sales) * (Sales / Assets) * (Assets / Equity)

ROE = Profit Margin * Asset Turnover Ratio * Equity Multiplier

The screener yields winning stocks like Mama's Creations Inc. (MAMA - Free Report) , Expeditors International of Washington (EXPD - Free Report) , W.W. Grainger (GWW - Free Report) and Everus Construction Group Inc. (ECG - Free Report) .

Why Use DuPont?Although one can’t play down the importance of normal ROE calculation, the fact remains that it doesn’t always provide a complete picture. The DuPont analysis, on the other hand, allows investors to assess the elements that play a dominant role in any change in ROE. It can help investors to segregate companies having higher margins from those having high turnover. For example, high-end fashion brands generally survive on high margin as compared with retail goods, which rely on higher turnover.

In fact, it also sheds light on the company’s leverage status, which can go a long way in selecting stocks poised for gains. A lofty ROE could be due to the overuse of debt. Thus, the strength of a company can be misleading if it has a high debt load.

So, an investor confined solely to an ROE perspective may be confused if he or she has to judge between two stocks of equal ratio. This is where DuPont analysis wins over and spots the better stock.

Investors can simply do this analysis by taking a look at the company’s financials.However, looking at the financial statements of each company separately can be a tedious task. Screening tools like Zacks Research Wizard can come to your rescue and help you shortlist the stocks that look impressive with a DuPont analysis.

Screening Parameters• Profit Margin more than or equal to 3: As the name suggests, it is a measure of how profitably the business is running. Generally, it is the key contributor to ROE.

• Asset Turnover Ratio more than or equal to 2: It allows an investor to assess management’s efficiency in using assets to drive sales.

• Equity Multiplier between 1 and 3: It’s an indication of how much debt the company uses to finance its assets.

• Zacks Rank less than or equal to 2: Stocks having a Zacks Rank #1 (Strong Buy) or 2 (Buy) generally perform better than their peers in all types of market environments.

• Current Price more than $5: This screens out the low-priced stocks. However, when looking for lower-priced stocks, this criterion can be removed.

Here are all four stocks that made it through the screen:

Mama's Creations Inc: The Zacks Rank #2 company manufactures and distributes fresh deli-prepared foods sold through more than 12,000 grocery, mass, club and convenience stores across the United States. You can see the complete list of today’s Zacks #1 Rank stocks here.

The average earnings surprise of MAMA for the past four quarters is 129.17%.

Expeditors International of Washington: The Zacks Rank #2 company is a leading third-party logistics provider.

The average earnings surprise of EXPD for the past four quarters is 13.96%.

W.W. Grainger:The Zacks Rank #2 company is a broad-line, business-to-business distributor of maintenance, repair and operating products and services.

The average earnings surprise of GWW for the past four quarters is 4.21%.

Everus Construction Group: The Zacks Rank #2 company is providing a full spectrum of construction services through its electrical and mechanical, and transmission and distribution specialty contracting services principally in the United States.

The average earnings surprise of ECG for the past four quarters is 61.97%.

In the latest bank forecasts, the Indian rupee could recover against the US dollar over the coming months as foreign bond inflows return and domestic liquidity conditions improve, according to HSBC. The bank recommends selling the USD/INR exchange rate, arguing that recent policy measures should encourage overseas investment into India while the Reserve Bank of India is likely to resist a renewed rise towards recent highs.

USD/INR was trading around 96.32 on Tuesday, having gained 1.75% during July and more than 7% since the beginning of the year.

The exchange rate recently reached a 2026 high around 97.12, placing the rupee close to levels that HSBC believes could trigger a more defensive response from policymakers.

Why Foreign Bond Inflows Could Support the Rupee HSBC says tax incentives for overseas bond investors included in the government's June foreign exchange package have already helped attract capital back into India.

Further inflows could follow if Bloomberg announces the inclusion of Indian debt in one of its bond indices.

Index inclusion would encourage international funds tracking the benchmark to increase their exposure to Indian government debt, generating additional demand for the rupee.

HSBC also notes that foreign investors have recently shifted from heavy equity selling to modest inflows, suggesting sentiment towards Indian assets may be stabilising.

How the FCNR Deposit Scheme Could Help Another potential source of support is the Foreign Currency Non-Resident deposit scheme.

HSBC says the initiative is beginning to gain traction as deposits are mobilised and exchanged with the Reserve Bank of India.

As more of these funds enter the domestic financial system, the resulting increase in rupee liquidity should have positive spillover effects for local sentiment, economic activity and Indian asset markets.

Combined with stronger foreign investment flows, this could help reverse some of the pressure that has driven USD/INR sharply higher during 2026.

Why the RBI May Defend the Rupee HSBC does not expect the Reserve Bank of India to sell substantial amounts of US dollars from its foreign exchange swap book.

Nevertheless, the bank believes officials are likely to remain defensive and prevent USD/INR from rising materially beyond current levels.

Allowing the pair to return towards 96-97 during the implementation of the government's currency package would raise questions over the effectiveness and cost of the measures.

This suggests the RBI may lean against further rupee weakness, particularly if USD/INR approaches its year-to-date high around 97.12.

What Could Push USD/INR Higher? HSBC acknowledges that the rupee still faces several risks.

India's dependence on imported energy means another rise in oil prices could increase demand for US dollars and widen the country's import bill.

Seasonal dividend outflows, renewed foreign selling of Indian equities and approaching non-deliverable forward maturities could also produce periods of rupee weakness.

The exchange rate has already risen from below 94.80 at the end of June to above 96.30, demonstrating that these risks remain significant.

What's the Forecast for the US Dollar versus the Indian Rupee? HSBC favours a lower USD/INR exchange rate and recommends selling the pair.

The bank expects returning foreign bond inflows, the FCNR deposit programme and resistance from the Reserve Bank of India to limit further gains in USD/INR.

While the pair may remain volatile around current levels, HSBC believes the balance of risks favours a stronger rupee rather than a sustained move beyond the recent 96-97 region.

USD/INR Forecast FAQIs HSBC bullish on the Indian rupee?

Yes. HSBC recommends selling USD/INR, which implies that it expects the rupee to strengthen against the US dollar.

What is the current USD/INR exchange rate?

USD/INR was trading around 96.32 on July 14. The pair was up approximately 1.75% for the month and 7.06% since the beginning of 2026.

Why does HSBC expect USD/INR to fall?

HSBC points to returning foreign bond investment, improving domestic liquidity and the likelihood that the Reserve Bank of India will resist a further rise in the exchange rate.

Could USD/INR rise above 97?

It remains possible if oil prices increase or foreign capital leaves Indian markets. However, HSBC expects the RBI to become increasingly defensive around the 96-97 region.

What are the main risks to the Indian rupee?

Higher oil prices, renewed equity outflows, seasonal dividend payments and non-deliverable forward maturities could all place fresh pressure on the Indian currency.

BEVERLY HILLS, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Kartoon Studios, Inc. (NYSE American: TOON) ("Kartoon Studios" or the "Company"), a global entertainment company creating, producing, distributing and licensing children's and family content, today announced that it has received the initial cash payment of approximately $39.2 million from its previously announced litigation settlements.

Following receipt of the initial settlement payment, Kartoon Studios has more than $40 million in cash and cash equivalents and no debt as of June 30, 2026, providing one of the strongest balance sheets in the Company's history. Importantly, the settlement proceeds were entirely non-dilutive, strengthening the Company's financial position without issuing a single additional share of stock or incurring debt. As a result, the Company is confident in its ability to execute its current strategic growth initiatives without any present need for additional equity financing or other dilutive capital.

"This is a transformational moment for Kartoon Studios," said Andy Heyward, Chairman and CEO of Kartoon Studios. "Our balance sheet has been strengthened with non-dilutive capital, allowing us to significantly increase our financial flexibility while preserving shareholder ownership. With more than $40 million in cash and cash equivalents and no debt as of June 30, 2026, we believe we have the resources necessary to execute our strategic plan from a position of strength while maintaining our disciplined approach to capital allocation."

Heyward continued, "The timing of this capital could not be more important. After more than five years of creative development and investment in precious key IP, we are approaching what we believe will be the two most significant franchise launches in Kartoon Studios' history.

 Copyright Kartoon Studios, Inc. 2026 

Hundred Acre Wood is our reimagining of the original A.A. Milne stories that introduced the world to Winnie-the-Pooh, one of the most beloved and commercially successful children's properties ever created. Alongside it, we have launched the Stan Lee Universe, beginning with Stan Lee's Superhero Pets, inspired by the imagination of the legendary Stan Lee, creator or co-creator of many of the world's most iconic superheroes, and one of the most commercially successful creators in entertainment history.

 Copyright Kartoon Studios, Inc. 2026

These are not simply new productions. They represent the culmination of years of investment in building enduring entertainment franchises with global licensing, merchandising, publishing, and distribution potential. Together with our expanding consumer products business and our owned streaming platforms, including Kartoon Channel! and Ameba, these launches represent the foundation of the Company's next phase of growth. We now have the financial strength to invest behind these launches from a position of confidence and stability and maximize their long-term value for our shareholders."

As previously disclosed on June 17, 2026, the U.S. District Court for the Southern District of New York entered the settlement agreements reached to date in the shareholder action Augenbaum v. Anson Investments Master Fund LP et al. (Case No. 1:22-CV-00249-AS). Under those settlements, Kartoon Studios is entitled to receive aggregate settlement proceeds of approximately $78.5 million, before counsel fees and other advisor costs.

The remaining settlement proceeds are held in escrow pending payment of final counsel fees and other advisor costs, after which the Company expects to receive the remaining net balance from escrow.

The Company believes its strengthened balance sheet positions Kartoon Studios to accelerate investment across its growing portfolio of owned intellectual property as it prepares for the commercial launch of Hundred Acre Wood and the Stan Lee Universe over the coming year. Combined with expanding licensing and merchandising initiatives, strategic global distribution relationships, and owned digital distribution platforms, the Company believes it is well positioned to build higher-margin recurring revenue streams and execute its long-term strategy of becoming a scaled global children's and family entertainment company centered on valuable, wholly owned franchises with enduring worldwide appeal.

About Kartoon Studios
Kartoon Studios (NYSE American: TOON) is a global, vertically integrated children’s and family entertainment company turning owned and controlled intellectual property into enduring, multi-platform franchises. The Company develops, produces, distributes, licenses and monetizes content across the full value chain, creating multiple revenue opportunities and long-term brand value.

Kartoon Studios’ growth portfolio includes Hundred Acre Wood’s Winnie & Friends and the Stan Lee Universe, alongside established brands and an extensive programming library. The Company operates Mainframe Studios and Toon Media Networks, as well as Beacon Media Group, a full-service marketing, communications, and media agency subsidiary of Kartoon Studios focused on children and family. Together, these assets provide production capabilities, direct audience access and distribution across linear television, AVOD, SVOD, FAST channels and streaming platforms in more than 60 territories. Kartoon Studios is focused on converting its intellectual property, infrastructure and global reach into scalable franchise growth and long-term shareholder value.

For more information, visit www.kartoonstudios.com.

Important Cautions Regarding Forward-Looking Statements

Certain statements in this press release that are not historical facts may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and are subject to risks and uncertainties. Forward-looking statements include statements concerning executing the Company’s current strategic growth initiatives without any present need for additional equity financing or other dilutive capital, having the resources necessary to execute the Company’s strategic plan from a position of strength while maintaining a disciplined approach to capital allocation, approaching the two most significant franchise launches in Kartoon Studios' history, the launches representing the foundation of the Company's next phase of growth together with its expanding consumer products business and owned streaming platforms, investing behind these launches from a position of confidence and stability and maximize their long-term value for the Company’s shareholders, being positioned to accelerate investment across a growing portfolio of owned intellectual property as the Company prepares for the commercial launch of Hundred Acre Wood and the Stan Lee Universe over the coming year, the Company being well positioned to build higher-margin recurring revenue streams and execute its long-term strategy of becoming a scaled global children's and family entertainment company centered on valuable, wholly owned franchises with enduring worldwide appeal and converting the Company’s intellectual property, infrastructure and global reach into scalable franchise growth and long-term shareholder value. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “will” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These statements are based on the Company’s current plans, estimates, assumptions and expectations and are not guarantees that such plans, estimates or expectations will be achieved. Actual events, results and performance may differ materially from those expressed or implied by these forward-looking statements due to various risks, uncertainties and other factors, including the Company’s ability to execute its business strategy and growth initiatives; changes in general economic, financial, market and industry conditions, the Company’s ability to execute its current strategic growth initiatives without any need for additional equity financing or other dilutive capital, having the resources necessary to execute the Company’s strategic plan from a position of strength, the ability to successfully launch the Company’s franchises, the Company's ability to enter its next phase of growth together and expand its consumer products business and owned streaming platforms, the ability to maximize long-term value for the Company’s shareholders, the ability to accelerate investments across a growing portfolio of owned intellectual property, the ability to obtain financing when needed; the Company’s ability to keep pace with technological advances; the Company’s ability to protect its intellectual property and other risks described under the heading “Risk Factors” in Part I, Item 1A of the Company’s most recent Annual Report on Form 10-K and in its other filings with the Securities and Exchange Commission, which are available at www.sec.gov. Additional risks and uncertainties that are not currently known to the Company or that the Company currently considers immaterial may also cause actual events, results or performance to differ materially from those expressed or implied by the forward-looking statements. All forward-looking statements speak only as of the date of this press release, and Kartoon Studios undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

INVESTOR RELATIONS CONTACT:
Lytham Partners, LLC
Robert Blum
602-889-9700
[email protected]

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/c8405e4d-1545-4935-b9c2-1762ca499fc4
https://www.globenewswire.com/NewsRoom/AttachmentNg/e0cf0186-d0ce-40d4-a456-7a03ee8bc9b7

Key Takeaways MU expanded its AI memory and storage portfolio for training and inference workloads.AMAT introduced new AI chip manufacturing systems for DRAM and advanced packaging.CSCO raised 2026 revenue guidance on AI infrastructure demand and expanded its NVIDIA partnership. Technology stocks have been taking a beating lately. However, the information technology sector has outperformed its peers and has primarily been responsible for the broader market rally over the past three years.

Artificial intelligence (AI), especially generative AI, stocks have emerged as the industry’s darling as their widespread adoption has been boosting Wall Street. The space is poised to get a further boost with the advent of agentic AI, while tech companies continue to pump billions of dollars into AI infrastructure.

Needless to say, the AI boom is far from over, and there’s still a lot of room to play, as the recent decline appears to be temporary. We have identified three AI-driven stocks that are poised to excel in the second half of 2026.

These three stocks are Micron Technology, Inc (MU - Free Report) , Applied Materials, Inc. (AMAT - Free Report) and Cisco Systems, Inc. (CSCO - Free Report) . Each of our picks currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Micron TechnologyMicron Technology, through its global brands, namely Micron, Crucial and Ballistix, markets high-performance memory and storage technologies, including Dynamic Random Access Memory (DRAM), NAND flash memory, NOR Flash and other technologies. The company’s solutions are used in leading-edge computing, consumer, networking, mobile, automotive, industrial and data center products. 

Micron Technology recently announced that it has reached a deal with Anthropic to co-design next-generation AI memory and storage architectures. The strategic partnership includes a long-term supply arrangement, Micron's investment in Anthropic's Series H funding round and deployment of Claude AI across Micron's engineering and manufacturing operations.

The company also recently launched its expanded portfolio of AI-optimized memory and storage products, which includes HBM4, a 256GB SOCAMM2 module, 256GB DDR5 RDIMMs, and the 245TB Micron 6600 ION SSD. The new range of products is aimed at boosting AI training and inference workloads from data centers to edge devices.

The company’s third-quarter fiscal 2026 revenue outlook of around $33.5 billion reflects strong AI infrastructure spending.

Moreover, Micron has a debt-to-equity ratio of 5.1%, which is lower than the Computer - Integrated System industry’s 36.8%. The company’s ROE stands at 72.4% compared to the sub-industry’s 22.1%.  The company has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year and next-quarter earnings has improved 26.1% and 46.3%, respectively, over the last 60 days.

Applied Materials, Inc.Applied Materials is a leading supplier of equipment used to manufacture semiconductor devices, flat panel displays and solar photovoltaic products. Applied Materials has given a boost to its AI semiconductor development through innovations in materials engineering, advanced packaging, and memory technologies.

The company earlier this year introduced new deposition, etch, and materials-modification systems to boost next-generation AI chips, including 2nm-and-beyond logic technologies.  Applied Materials has also announced the acquisition of NEXX in a bid to expand its advanced packaging capabilities. The technology will help larger AI accelerator designs using chiplets, HBM stacks, and advanced substrates, giving more powerful AI systems.

Last month, Applied Materials introduced new semiconductor manufacturing systems that are focused on DRAM and advanced packaging for AI chips. These will allow higher-yield HBM stacking and improved AI accelerator performance.

The Zacks Rank #1 company has a debt-to-equity ratio of 22%, which is lower than the Electronics-Semiconductors industry’s 66.3%. The company’s ROE stands at 37% compared to the sub-industry’s 35.2%. The company has an expected earnings growth rate of 28.8% for the current year. The Zacks Consensus Estimate for current-year and next-quarter earnings has improved 8.7% and 8.6%, respectively, over the last 60 days.

Cisco Systems, Inc.Cisco Systems has given a boost to its AI strategy by developing secure, high-performance networking infrastructure for the AI era. Last year, the Zacks Rank #1 company expanded its partnership with NVIDIA Corporation (NVDA - Free Report) , combining Cisco Silicon One networking technology with NVIDIA Spectrum-X to come up with AI-ready data center architectures.

Cisco also launched the Cisco Secure AI Factory with NVIDIA, integrating networking, security, and AI infrastructure solutions to simplify enterprise AI deployment. Earlier, Cisco introduced AI-ready data center innovations, including AI PODs, Unified Nexus Dashboard improvements and Spectrum-X integration.

Cisco Systems raised its 2026 revenue guidance to $62.8-$63.0 billion, driven by solid demand for AI data-center infrastructure and massive cloud-provider orders.

Cisco has a debt-to-equity ratio of 39.6%, which is lower than the Computer-Networking industry’s 44.7%%. The company’s ROE stands at 34.3% compared to the sub-industry’s 27.9%. The company has an expected earnings growth rate of 12.3% for the current year. The Zacks Consensus Estimate for current-year and next-quarter earnings has improved 2.6% and 5.5%, respectively, over the last 60 days.

Best Buy: Managing a Massive Revenue BaseBest Buy (BBY 1.39%) primarily generates revenue by selling a wide array of consumer electronics, household appliances, and entertainment products, alongside offering consultation, repair, and technical support services to its customers.

It recently appointed Jason Bonfig as its new Chief Executive Officer, and for the quarter ended May 2, 2026, it reported a net income margin of 3%.

GameStop: Smaller Scale With Similar Seasonal ShiftsGameStop (GME +0.29%) earns most of its revenue by providing new and pre-owned video game consoles, software, and accessories, along with digital gaming content and licensed pop culture merchandise.

It recently submitted an unsolicited proposal to acquire eBay for $55.5 billion, which eBay’s Board of Directors rejected. For the quarter ended May 2, 2026, it recorded a net income margin of 47%.

Why Revenue Matters for Retail InvestorsRevenue here represents the total money a company brings in from its operations before any expenses are deducted, which helps investors gauge overall customer demand and business scale.

Quarterly Revenue for Best Buy and GameStopQuarter (Period End)Best Buy RevenueGameStop RevenueQ3 2024 (Aug. 2024)$9.3 billion$798.3 millionQ4 2024 (Nov. 2024)$9.4 billion$860.3 millionQ1 2025$13.9 billion (period ended Feb. 2025)$1.3 billion (period ended Jan. 2025)Q2 2025 (May 2025)$8.8 billion$732.4 millionQ3 2025 (Aug. 2025)$9.4 billion$972.2 millionQ4 2025 (Nov. 2025)$9.7 billion$821.0 millionQ1 2026 (Jan. 2026)$13.8 billion$1.1 billionQ2 2026 (May 2026)$8.9 billion$835.3 millionData source: Company filings. Data as of July 13, 2026.

Foolish TakeAs is typical for retailers, Best Buy and GameStop experience sales spikes over the holiday shopping season in November and December. The former’s vastly higher revenue illustrates how the electronics retailer successfully navigated shifts in its business as consumers abandoned physical movie and video game media for digital versions. Its sales edged up to $8.9 billion in its fiscal first quarter ended May 2 compared to $8.8 billion in the prior year.

GameStop is attempting to adjust to changes in shopping behavior by introducing collectibles, which helped drive 14% year-over-year sales growth in its fiscal first quarter ended May 2. The company also posted the highest quarterly net income in its history, reaching $389.6 million, as a result of a confluence of cost management, higher revenue, and gains on investments such as Bitcoin.

Over the long term, Best Buy stands to see continued revenue growth. It has diversified across computers, appliances, mobile phones, and other products that provide resilience against economic headwinds. Meanwhile, GameStop still needs to prove it has a sustainable business as its core video games offering is in rapid decline, especially after Sony announced its PlayStation console will only sell digital content starting in 2028.

SummaryCompaniesU.S. states argue merger would hurt traditional media industriesStates say merged entity would own 27% of theatrical marketDeal also would combine 2nd- and 3rd-largest basic cable networksJuly 14 - U.S. states suing to block Paramount’s PSKY.O merger with Warner Bros Discovery (WBD.O), opens new tab argue that the deal could squeeze local movie theaters, which are still struggling to ​sell as many tickets as they did before the pandemic.

“While ticket prices will most likely go up, theaters will be forced to cut back ‌on investments that make the experience better for audiences: comfier seats, expanded concessions, and premium screens,” California Attorney General Rob Bonta said at a news conference Monday, standing in front of the Hollywood sign.

Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.

If completed, the merger would combine two of the nation’s five major film distributors, and further concentrate ownership of cable television networks. The new entity would have unfair bargaining leverage over theater-owners and pay-TV operators, ​according to the complaint.

With fewer film distributors, studios could find it easier to pressure theater owners for a greater share of ticket revenue, alleges the complaint, ​filed by California and 11 other states including Oregon, New York and Minnesota.

Basic cable TV providers would also lose leverage, the states said.

The ⁠deal would concentrate Paramount’s market power in both movie theaters and in basic cable to more than 27% each, according to the complaint.

“Your cable bill is going to ​go up because those cable companies that distribute the channels will have less negotiating power,” said Bonta.

Paramount, led by CEO David Ellison, issued a statement saying the lawsuit distorts settled ​antitrust law and is based on a misrepresentation of competition in the entertainment industry.

“Delaying this transaction will only harm entertainment workers who have already suffered over recent years as technology has disrupted their livelihood and cost California tens of thousands of entertainment jobs,” Paramount said.

Delaying the deal will also be costly for Paramount. Ellison has agreed to pay Warner Bros. Discovery shareholders a 25-cent-per-share "ticking fee," amounting to ​about $650 million in cash each quarter, if the deal does not close before October.

Cinema United, a trade group for theater owners that has been lobbying against the deal, welcomed ​the lawsuit.

“The ramifications of further movie studio consolidation will be significant and lasting, not just in Hollywood, but on Main Streets across this nation where local movie theaters serve as cultural and ‌financial cornerstones ⁠for communities of all sizes,” Cinema United President and CEO Michael O’Leary said in a statement.

One executive with an independent theater chain, who asked not to be named, worried that a combined Paramount and Warner Bros could raise the rental fee theater owners pay to show the blockbuster films that attract large audiences. Studios and theaters have traditionally split the proceeds from movie ticket sales evenly, though studios can command as much as 60% of proceeds for highly anticipated movies.

“Theaters will have no recourse,” said the source, who requested ​anonymity for fear of antagonizing Paramount.

As film distributors ​siphon off a greater percentage of ⁠box-office proceeds, theater owners may be forced to raise ticket prices, or to spend less on improvements, the complaint alleges. To better compete for viewers in the streaming era, theaters have been upgrading their facilities with improvements such as more comfortable seats and a ​wider variety of refreshments.

Year-to-date box office receipts in the U.S. and Canada stand at $5.1 billion in 2026, 10.6% higher than last ​year but 16.3% below ⁠the pre-pandemic year of 2019, according to Rentrak data.

Echoing cinema operators, Bonta said the industry was hurt by a previous media merger: the 2019 Walt Disney (DIS.N), opens new tab acquisition of entertainment assets owned by Fox.

From 2015 to 2018, Disney and Fox distributed 112 wide-release films. That number dropped to 54 for 2022 to 2025, the lawsuit said.

The merger also would harm cable TV providers who bring the ⁠companies' networks into ​American living rooms, the complaint alleged, since Warner and Paramount will no longer compete to market their ​networks.

A deal would combine a range of popular networks, including CNN, TNT, Food Network and HBO, enhancing the company's “bargaining leverage over distributors.”

TV providers would have “little choice” but to accept the company's deal terms, according to the ​suit.

The complaint does not take issue with Paramount’s plans to combine its Paramount+ streaming service with Warner Bros’ HBO Max.

Reporting by Dawn Chmielewski and Lisa Richwine; Editing by David Gregorio

Our Standards: The Thomson Reuters Trust Principles., opens new tab